Pet成像
神经科学
化学
正电子发射断层摄影术
兴奋剂
生物神经网络
配体(生物化学)
非人灵长类
神经影像学
分子成像
神经活动
受体
功能成像
运动前神经元活动
电生理学
临床前影像学
化学生物学
神经网络
放射性配体
药物发现
大脑定位
中枢神经系统
人脑
临床前研究
药理学
脑功能成像
哺乳动物大脑
作者
Baijayantimala Swain,Jeih-San Liow,B. Li,Alfred B. Jenson,Matilah Pamie-George,Sami S. Zoghbi,Juan L. Gomez,Michael Michaelides,Chris Magnus,Scott M. Sternson,Barry J. Richmond,Marc H. Schieber,Sanjay Telu,Robert B. Innis,VW Pike
标识
DOI:10.1021/acs.jmedchem.5c02679
摘要
Chemogenetic technologies offer a powerful approach to modulating neural circuits with high precision and hold promise for therapeutic applications in neuropsychiatric disorders. However, translating these tools for noninvasive monitoring in the primate brain has been limited by a lack of suitable positron emission tomography (PET) radioligands. Existing ultrapotent ligands activate PSAM receptors, but the PET ligand [11C]uPSEM792 shows poor brain penetration, and [18F]ASEM lacks receptor specificity. To address this, we developed novel chemogenetic ligands with improved brain permeability and radiolabeled them with fluorine-18. Two candidates, PSG07 and PSN09, showed a high-affinity and potent agonist activity at PSAM4-GlyR and PSAM4-5-HT3 receptors. Monkey PET imaging showed tracer localization at the PSAM4-GlyR expression site, with [18F]PSN09 displaying a detectable signal. Functional imaging with [18F]FDG further confirmed neuronal inhibition following administration of PSG07 and PSN09. These findings highlight PSG07 and PSN09 as promising chemogenetic actuators with the potential as radioligands for translational PET imaging in nonhuman primates.
科研通智能强力驱动
Strongly Powered by AbleSci AI